The US Food and Drug Administration (FDA) on Thursday warned that the antibiotic azithromycin (Zithromax, Zmax) should not be given long-term to prevent a certain inflammatory lung condition, known as ...

Patients taking azithromycin should not stop taking it without consulting a clinician, the FDA added. The issue of macrolides and the risk for cardiovascular death has been on the FDA's radar since ...

FDA Safety Changes: Zithromax, Frova, Lexiscan The FDA has approved safety labeling revisions for azithromycin tablets and oral suspension (Zithromax), frovatriptan succinate tablets (Frova), and ...

Preschool children with moderate to severe wheezing gained no clinical benefit from azithromycin treatment compared with ...

Findings showed zoliflodacin was noninferior to ceftriaxone plus azithromycin (microbiological cure rate, 90.9% vs 96.2%, respectively; difference, 5.3%). The Food and Drug Administration (FDA) has ...